The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck.
This study examines the value of squamous cell cancer (SCC) antigen in patients irradiated for locally advanced cancer of the head and neck. In 20 patients (group A) treated with radiochemotherapy and in 20 patients (group B) receiving postoperative irradiation serum SCC values were investigated. The pretreatment SCC level was 1.6 ng/ml in group A and 1.3 ng/ml in group B. In group A 15% had elevated serum SCC levels above the cut-off level. In group B there were 10%. During follow-up (median 20 months), 10 patients in group A and 8 in group B suffered from a recurrent or progressing disease. Of these 20% in group A and 12.5% in group B had elevated SCC levels. Our results suggest that, in the described patient groups, SCC is probably of low value for tumor diagnosis and follow-up.